Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 78
Filter
2.
BMC Infect Dis ; 18(1): 576, 2018 Nov 15.
Article in English | MEDLINE | ID: mdl-30442123

ABSTRACT

BACKGROUND: Since macrophages are one of the major cell types involved in the Mycobacterium leprae immune response, roles of the M1 and M2 macrophage subpopulations have been well defined. However, the role of M4 macrophages in leprosy or other infectious diseases caused by mycobacteria has not yet been clearly characterized. This study aimed to investigate the presence and potential role of M4 macrophages in the immunopathology of leprosy. METHODS: We analyzed the presence of M4 macrophage markers (CD68, MRP8, MMP7, IL-6, and TNF-α) in 33 leprosy skin lesion samples from 18 patients with tuberculoid leprosy and 15 with lepromatous leprosy by immunohistochemistry. RESULTS: The M4 phenotype was more strongly expressed in patients with the lepromatous form of the disease, indicating that this subpopulation is less effective in the elimination of the bacillus and consequently is associated with the evolution to one of the multibacillary clinical forms of infection. CONCLUSION: M4 macrophages are one of the cell types involved in the microbial response to M. leprae and probably are less effective in controlling bacillus replication, contributing to the evolution to the lepromatous form of the disease.


Subject(s)
Leprosy/metabolism , Macrophages/metabolism , Mycobacterium leprae/immunology , Skin Diseases/metabolism , Skin/metabolism , Adult , Biomarkers/metabolism , Brazil , Female , Humans , Immunohistochemistry , Leprosy/immunology , Leprosy/pathology , Leprosy, Lepromatous/immunology , Leprosy, Lepromatous/metabolism , Leprosy, Lepromatous/pathology , Leprosy, Tuberculoid/immunology , Leprosy, Tuberculoid/metabolism , Leprosy, Tuberculoid/pathology , Macrophages/immunology , Macrophages/pathology , Male , Skin/immunology , Skin/pathology , Skin Diseases/immunology , Skin Diseases/microbiology , Skin Diseases/pathology
3.
Microb Pathog ; 118: 277-284, 2018 May.
Article in English | MEDLINE | ID: mdl-29605649

ABSTRACT

Mast cells (MCs) have important immunoregulatory roles in skin inflammation. Annexin A1 (ANXA1) is an endogenous anti-inflammatory protein that can be expressed by mast cells, neutrophils, eosinophils, monocytes, epithelial and T cells. This study investigated MCs heterogeneity and ANXA1 expression in human dermatoses with special emphasis in leprosy. Sixty one skin biopsies from 2 groups were investigated: 40 newly diagnosed untreated leprosy patients (18 reaction-free, 11 type 1 reaction/T1R, 11 type 2 reaction/T2R); 21 patients with other dermatoses. Tryptase/try+ and chymase/chy + phenotypic markers and toluidine blue stained intact/degranulated MC counts/mm2 were evaluated. Try+/chy+ MCs and ANXA1 were identified by streptavidin-biotin-peroxidase immunostaining and density was reported. In leprosy, degranulated MCs outnumbered intact ones regardless of the leprosy form (from tuberculoid/TT to lepromatous/LL), leprosy reactions (reactional/reaction-free) and type of reaction (T1R/T2R). Compared to other dermatoses, leprosy skin lesions showed lower numbers of degranulated and intact MCs. Try+ MCs outnumbered chy+ in leprosy lesions (reaction-free/reactional, particularly in T2R), but not in other dermatoses. Compared to other dermatoses, ANXA1 expression, which is also expressed in mast cells, was higher in the epidermis of leprosy skin lesions, independently of reactional episode. In leprosy, higher MC degranulation and differential expression of try+/chy+ subsets independent of leprosy type and reaction suggest that the Mycobacterium leprae infection itself dictates the inflammatory MCs activation in skin lesions. Higher expression of ANXA1 in leprosy suggests its potential anti-inflammatory role to maintain homeostasis preventing tissue and nerve damage.


Subject(s)
Annexin A1/biosynthesis , Annexin A1/immunology , Anti-Inflammatory Agents/immunology , Anti-Inflammatory Agents/metabolism , Leprosy/immunology , Leprosy/metabolism , Mast Cells/metabolism , Adult , Aged , Aged, 80 and over , Biopsy , Brazil , Chymases/metabolism , Epidermis/immunology , Epidermis/pathology , Female , Humans , Leprosy/pathology , Leprosy, Lepromatous/metabolism , Leprosy, Tuberculoid/metabolism , Male , Mast Cells/pathology , Middle Aged , Mycobacterium leprae/immunology , Mycobacterium leprae/pathogenicity , Skin/pathology , Skin Diseases/metabolism , Skin Diseases/pathology , Tryptases/metabolism , Young Adult
4.
Dis Markers ; 2018: 7067961, 2018.
Article in English | MEDLINE | ID: mdl-30647798

ABSTRACT

Mycobacterium leprae causes leprosy, a dermatoneurological disease which affects the skin and peripheral nerves. One of several cellular structures affected during M. leprae infection is the endoplasmic reticulum (ER). Infection by microorganisms can result in ER stress and lead to the accumulation of unfolded or poorly folded proteins. To restore homeostasis in the cell, the cell induces a series of signaling cascades known as the unfolded protein response called UPR (unfolded protein response). The present work is aimed at investigating the in situ expression of these markers in cutaneous lesions of clinical forms of leprosy and establish possible correlation expression patterns and types of lesion. A total of 43 samples from leprosy patients were analyzed by immunohistochemistry with monoclonal antibodies against GRP78/BiP, PERK, IRE1α, and ATF6. A statistically significant difference between the indeterminate, tuberculoid, and lepromatous clinical forms was detected, with high expression of GRP78/BiP, PERK, IRE1α, and ATF6 in tuberculoid forms (TT) when compared to lepromatous leprosy (LL) and indeterminate (I) leprosy. These results represent the first evidence of ER stress in samples of skin lesions from leprosy patients. We believe that they will provide better understanding of the complex pathogenesis of the disease and facilitate further characterization of the cascade of molecular events elicited during infection.


Subject(s)
Biomarkers/metabolism , Endoplasmic Reticulum Stress , Leprosy, Lepromatous/diagnosis , Leprosy, Tuberculoid/diagnosis , Activating Transcription Factor 6/metabolism , Diagnosis, Differential , Endoplasmic Reticulum Chaperone BiP , Endoribonucleases/metabolism , Heat-Shock Proteins/metabolism , Humans , Leprosy/classification , Leprosy/metabolism , Leprosy, Lepromatous/metabolism , Leprosy, Tuberculoid/metabolism , Protein Serine-Threonine Kinases/metabolism , Signal Transduction , Up-Regulation , eIF-2 Kinase/metabolism
5.
Microbes Infect ; 19(11): 505-514, 2017 11.
Article in English | MEDLINE | ID: mdl-28684130

ABSTRACT

Our previous study has demonstrated that IL-10 may modulate both indoleamine 2,3-dioxygenase (IDO) and CD163 expression in lepromatous leprosy (LL) cells, favoring Mycobacterium leprae persistence through induction of regulatory pathways and iron storage. Here, we observed that in LL lesion cells there is an increase in the expression of proteins involved in iron metabolism such as hemoglobin (Hb), haptoglobin, heme oxygenase 1 and transferrin receptor 1 (TfR1) when compared to tuberculoid leprosy (BT) cells. We also found increased iron deposits and diminished expression of the iron exporter ferroportin 1 in LL lesion cells. Hemin, but not FeSO4 stimulation, was able to enhance M. leprae viability by a mechanism that involves IDO. Analysis of cell phenotype in lesions demonstrated a predominance of M2 markers in LL when compared with BT lesion cells. A positive correlation between CD163 and PPARG with the bacillary index (BI) was observed. In contrast, TNF, STAT1 and CSF2 presented a negative correlation with the BI. In summary, this study demonstrates that iron may regulate IDO expression by a mechanism that involves IL-10, which may contribute for the predominance of M2-like phenotype in LL lesions that favors the phagocytosis and maintenance of M. leprae in host cells.


Subject(s)
Indoleamine-Pyrrole 2,3,-Dioxygenase/physiology , Iron/physiology , Mycobacterium leprae/physiology , Adult , Female , Humans , Immunoblotting , Immunoenzyme Techniques , Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism , Iron/metabolism , Leprosy, Lepromatous/metabolism , Leprosy, Lepromatous/microbiology , Male , Middle Aged , Mycobacterium leprae/metabolism , Reverse Transcriptase Polymerase Chain Reaction
6.
s.l; Elsevier; 2017. 10 p. tab, graf.
Non-conventional in English | HANSEN, Sec. Est. Saúde SP, Hanseníase Leprosy, SESSP-ILSLPROD, Sec. Est. Saúde SP, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1052567

ABSTRACT

Our previous study has demonstrated that IL-10 may modulate both indoleamine 2,3-dioxygenase (IDO) and CD163 expression in lepromatous leprosy (LL) cells, favoring Mycobacterium leprae persistence through induction of regulatory pathways and iron storage. Here, we observed that in LL lesion cells there is an increase in the expression of proteins involved in iron metabolism such as hemoglobin (Hb), haptoglobin, heme oxygenase 1 and transferrin receptor 1 (TfR1) when compared to tuberculoid leprosy (BT) cells. We also found increased iron deposits and diminished expression of the iron exporter ferroportin 1 in LL lesion cells. Hemin, but not FeSO stimulation, was able to enhance M. leprae viability by a mechanism that involves IDO. Analysis of cell phenotype in lesions demonstrated a predominance of M2 markers in LL when compared with BT lesion cells. A positive correlation between CD163 and PPARG with the bacillary index (BI) was observed. In contrast, TNF, STAT1 and CSF2 presented a negative correlation with the BI. In summary, this study demonstrates that iron may regulate IDO expression by a mechanism that involves IL-10, which may contribute for the predominance of M2-like phenotype in LL lesions that favors the phagocytosis and maintenance of M. leprae in host cells.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Immunoblotting , Leprosy, Lepromatous/metabolism , Leprosy, Lepromatous/microbiology , Immunoenzyme Techniques , Reverse Transcriptase Polymerase Chain Reaction , Indoleamine-Pyrrole 2,3,-Dioxygenase/physiology , Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism , Iron/physiology , Iron/metabolism , Mycobacterium leprae/physiology , Mycobacterium leprae/metabolism
7.
Indian J Lepr ; 88(2): 129-131, 2016 04.
Article in English | MEDLINE | ID: mdl-29757546

ABSTRACT

Elastophagocytosis is the engulfment of the elastic fibres by the histiocytes, multinucleated giant cells, or both. The cutaneous lesions showing elastophagocytosis are annular elastolytic giant cell granuloma, actinic keratoses, persistent insect-bite reactions, elastosis perforans serpiginosa, foreign body granuloma. Occasionally, it may occur in infectious diseases like leprosy, granulomatous syphilis, North-American blastomycosis, bacterial folliculitis, and cutaneous leishmaniasis. We report a case of lepromatous leprosy with necrotic erythema nodosum leprosum with secondary anetoderma. Histopathology from the atrophic macule of anetoderma revealed periappendageal, perineural infiltration, elastophagocytosis and reduction in elastic fibres.


Subject(s)
Elastic Tissue/metabolism , Leprosy, Lepromatous/diagnosis , Phagocytosis , Anetoderma/diagnosis , Anetoderma/etiology , Anetoderma/metabolism , Anetoderma/pathology , Elastic Tissue/pathology , Erythema Nodosum/diagnosis , Erythema Nodosum/etiology , Erythema Nodosum/metabolism , Erythema Nodosum/pathology , Histiocytes/physiology , Humans , Leprosy, Lepromatous/complications , Leprosy, Lepromatous/metabolism , Leprosy, Lepromatous/pathology , Male , Middle Aged
8.
Article in English | MEDLINE | ID: mdl-26515838

ABSTRACT

BACKGROUND: Leprosy is a chronic granulomatous infection caused by Mycobacterium leprae, an intracellular parasite that resides within macrophages and cannot be eliminated effectively. Solute carrier family 11a member 1 (Slc11a1) and inducible nitric oxide synthase (iNOS), both expressed in macrophages, play major roles in host defense against several intracellular pathogens. However, the roles of these molecules in natural infection with M. leprae remain unknown. OBJECTIVE: We aimed to investigate the expression of Slc11a1 and iNOS in macrophages (CD68+ cells) infiltrating skin lesions in leprosy. METHODS: Skin biopsies from 48 Mexican patients of leprosy [(33 lepromatous (LL), 15 tuberculoid (TT)] and from 10 healthy controls, were subjected to immunohistochemistry to determine expression of CD68, Slc11a1 and iNOS. RESULTS: We found a high expression of Slc11a1 and iNOS in most lepromatous leprosy samples. In tuberculoid leprosy samples, Slc11a1 expression was moderate or low, and that of iNOS was almost always low. In addition, Slc11a1 and iNOS expression levels were positively associated with bacillary loads in lepromatous leprosy lesions (P=0.05). CONCLUSIONS: These observations suggest that M. leprae infection promotes the expression of Slc11a1 and iNOS in macrophages and that lepromatous leprosy can occur despite this response.


Subject(s)
Cation Transport Proteins/analysis , Leprosy, Lepromatous/metabolism , Leprosy, Tuberculoid/metabolism , Macrophages/chemistry , Nitric Oxide Synthase Type II/analysis , Adult , Aged , Antigens, CD/analysis , Antigens, Differentiation, Myelomonocytic/analysis , Case-Control Studies , Female , Humans , Leprosy, Lepromatous/pathology , Leprosy, Tuberculoid/pathology , Male , Middle Aged
9.
J Invest Dermatol ; 135(10): 2410-2417, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26030183

ABSTRACT

The mechanisms by which intracellular pathogens trigger immunosuppressive pathways are critical for understanding the pathogenesis of microbial infection. One pathway that inhibits host defense responses involves the induction of type I interferons and subsequently IL-10, yet the mechanism by which type I IFN induces IL-10 remains unclear. Our studies of gene expression profiles derived from leprosy skin lesions suggested a link between IL-27 and the IFN-ß induced IL-10 pathway. Here, we demonstrate that the IL-27p28 subunit is upregulated following treatment of monocytes with IFN-ß and Mycobacterium leprae, the intracellular bacterium that causes leprosy. The ability of IFN-ß and M. leprae to induce IL-10 was diminished by IL-27 knockdown. Additionally, treatment of monocytes with recombinant IL-27 was sufficient to induce the production of IL-10. Functionally, IL-27 inhibited the ability of IFN-γ to trigger antimicrobial activity against M. leprae in infected monocytes. At the site of disease, IL-27 was more strongly expressed in skin lesions of patients with progressive lepromatous leprosy, correlating and colocalizing with IFN-ß and IL-10 in macrophages. Together, these data provide evidence that in the human cutaneous immune responses to microbial infection, IL-27 contributes to the suppression of host antimicrobial responses.


Subject(s)
Interferon-beta/pharmacology , Interleukin-10/metabolism , Interleukin-27/metabolism , Leprosy, Lepromatous/drug therapy , Leprosy, Lepromatous/metabolism , Mycobacterium leprae/metabolism , Animals , Biomarkers/metabolism , Cells, Cultured , Cytokines/metabolism , Enzyme-Linked Immunosorbent Assay , Humans , Immunosuppressive Agents/pharmacology , Interleukin-27/pharmacology , Leprosy, Lepromatous/pathology , Mice , Microscopy, Confocal , Models, Animal , Monocytes/cytology , Monocytes/drug effects , Mycobacterium leprae/pathogenicity , Prognosis , RNA, Small Interfering/metabolism , Real-Time Polymerase Chain Reaction/methods , Sampling Studies , Sensitivity and Specificity , Transfection
10.
Acta Trop ; 149: 227-31, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26051909

ABSTRACT

Leprosy is an infectious-contagious disease whose clinical evolution depends on the immune response pattern of the host. Adhesion molecules and leukocyte migration from blood to tissue are of the utmost importance for the recognition and elimination of infectious pathogens. Selectins are transmembrane glycoproteins that share a similar structural organization and can be divided into three types according to their site of expression. The biopsies were cut into 5µm thick sections and submitted to immunohistochemistry using antibodies against E-selectin and P-selectin. The number of E-selectin-positive cells was significantly higher in the tuberculoid form than in the lepromatous form. The immunostaining pattern of P-selectin differed from that of E-selectin. Analysis showed a larger number of endothelial cells expressing CD62P in the lepromatous form compared to the tuberculoid form. The presence of these adhesins in the endothelium contributing to or impairing the recruitment of immune cells to inflamed tissue and consequently influences the pattern of immune response and the clinical presentation of the disease.


Subject(s)
E-Selectin/metabolism , Endothelial Cells/metabolism , Endothelium, Vascular/metabolism , Leprosy, Lepromatous/metabolism , Leprosy, Tuberculoid/metabolism , P-Selectin/metabolism , Skin/metabolism , Cell Adhesion Molecules , Endothelium, Vascular/cytology , Humans , Immunohistochemistry
11.
Science ; 339(6126): 1448-53, 2013 Mar 22.
Article in English | MEDLINE | ID: mdl-23449998

ABSTRACT

Type I interferons (IFN-α and IFN-ß) are important for protection against many viral infections, whereas type II interferon (IFN-γ) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN-ß and IFN-γ gene expression programs. IFN-γ and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN-ß and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN-γ-induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN-ß and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections.


Subject(s)
Interferon-beta/immunology , Interferon-gamma/immunology , Leprosy, Lepromatous/immunology , Leprosy, Tuberculoid/immunology , Mycobacterium leprae/immunology , 25-Hydroxyvitamin D3 1-alpha-Hydroxylase/genetics , 25-Hydroxyvitamin D3 1-alpha-Hydroxylase/metabolism , Antimicrobial Cationic Peptides/genetics , Antimicrobial Cationic Peptides/metabolism , Humans , Interferon-beta/genetics , Interferon-beta/metabolism , Interferon-gamma/genetics , Interferon-gamma/metabolism , Interleukin-10/genetics , Interleukin-10/metabolism , Leprosy, Lepromatous/genetics , Leprosy, Lepromatous/metabolism , Leprosy, Tuberculoid/genetics , Leprosy, Tuberculoid/metabolism , Microbial Viability , Monocytes/immunology , Monocytes/metabolism , Mycobacterium leprae/physiology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Calcitriol/genetics , Receptors, Calcitriol/metabolism , Transcriptome , Tuberculosis/genetics , Tuberculosis/immunology , Up-Regulation , beta-Defensins/genetics , beta-Defensins/metabolism , Cathelicidins
12.
Lepr Rev ; 84(3): 176-85, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24428111

ABSTRACT

Histoid leprosy is a rare multibacillary form that presents with disseminated papule-nodular cutaneous lesions. To study the inflammatory infiltrate of the histoid form and to compare it with other lepromatous forms, we performed histological and immunohistochemical analysis on skin biopsies. Fifteen patients were included for histopathological analysis (10 histoid and five lepromatous) via the haematoxylin-eosin and Ziehl-Neelsen-Faraco stains. Thus, immunohistochemical techniques using immunoperoxidase assay were performed for: anti-BCG, anti-M. leprae, anti-CD8, anti-CD3, anti-CD20, anti-S100, anti-CD1a, anti-CD68 and antivimentin. Spindle cells were present in all histoid patients. A pseudocapsule was observed in half of both studied forms. A comparison using the Ziehl-Neelsen-Faraco stain to evaluate anti-BCG and anti-M.leprae showed no major differences. The CD3+ cells were more pronounced in the histoid form than the lepromatous form. There was greater immunoreactivity toward CD8+ cells in the histoid form, as well as the CD20+ cell count. A similar count of S100+ cells in the epidermis of both leprosy forms was observed. There was a slight increase of dendritic cells in the histoid patients in the superficial and deep dermis. For CD1a marker, we observed expression in the epidermis and superficial dermis in both forms. A diffuse and intense infiltrate of CD68+ cells was also observed in the histoid and lepromatous forms. The high positivity for vimentin did not allow for a positive cell count. We concluded that the activation of both the cellular and humoral response is more pronounced in the histoid form because the T and B cells showed greater infiltration than those in the lepromatous form. The activation of dendritic and Langerhans cells is similar in both forms. The spindle cells likely belong to the macrophage population, thus maintaining phagocytic ability. The quantities of pseudocapsules and bacilli are similar and cannot serve as criteria for diagnosis.


Subject(s)
Leprosy, Lepromatous/metabolism , Leprosy, Lepromatous/pathology , Leprosy, Multibacillary/metabolism , Leprosy, Multibacillary/pathology , Adult , Female , Humans , Immunohistochemistry , Male , Middle Aged , Retrospective Studies , Skin/chemistry , Skin/metabolism , Skin/pathology
13.
Diagn Cytopathol ; 41(4): 366-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-21932352

ABSTRACT

Erythema nodosum leprosum (ENL) or type 2 lepra reaction is an inflammatory reaction, which may occur in the course of hanseniasis, may compel the patient to seek medical attention and may result in nerve function impairment and subsequent disability. Thus, recognition and timely management of these patients is critical in order to avoid permanent disability. Fine-needle aspiration cytology is simple and effective tool that aids in the correct diagnosis and management of ENL. Herein, we present two cases of ENL, one with typical and another with atypical presentation.


Subject(s)
Erythema Nodosum/diagnosis , Leprosy, Lepromatous/diagnosis , Mycobacterium leprae/isolation & purification , Skin/microbiology , Biopsy, Fine-Needle , Child , Erythema Nodosum/metabolism , Female , Humans , Leprosy, Lepromatous/metabolism , Macrophages/pathology , Male , Mycobacterium leprae/pathogenicity , Neutrophils/metabolism , Skin/metabolism , Skin Diseases, Bacterial/diagnosis , Staining and Labeling
14.
J Infect Dis ; 207(6): 947-56, 2013 Mar 15.
Article in English | MEDLINE | ID: mdl-23255567

ABSTRACT

Galectin-3 is a ß-galactoside-binding lectin widely expressed on epithelial and hematopoietic cells, and its expression is frequently associated with a poor prognosis in cancer. Because it has not been well-studied in human infectious disease, we examined galectin-3 expression in mycobacterial infection by studying leprosy, an intracellular infection caused by Mycobacterium leprae. Galectin-3 was highly expressed on macrophages in lesions of patients with the clinically progressive lepromatous form of leprosy; in contrast, galectin-3 was almost undetectable in self-limited tuberculoid lesions. We investigated the potential function of galectin-3 in cell-mediated immunity using peripheral blood monocytes. Galectin-3 enhanced monocyte interleukin 10 production to a TLR2/1 ligand, whereas interleukin 12p40 secretion was unaffected. Furthermore, galectin-3 diminished monocyte to dendritic cell differentiation and T-cell antigen presentation. These data demonstrate an association of galectin-3 with unfavorable host response in leprosy and a potential mechanism for impaired host defense in humans.


Subject(s)
Galectin 3/pharmacology , Leprosy, Lepromatous/immunology , Leprosy, Tuberculoid/immunology , Monocytes/metabolism , Antigen Presentation/drug effects , Antigens, CD1/metabolism , Cell Differentiation/drug effects , Galectin 3/genetics , Galectin 3/metabolism , Gene Expression , Humans , Immunity, Cellular , Immunity, Innate , Interleukin-10/metabolism , Interleukin-12 Subunit p40/metabolism , Leprosy, Lepromatous/metabolism , Leprosy, Tuberculoid/metabolism , Macrophages/metabolism , Monocytes/drug effects , Mycobacterium leprae , RNA, Messenger/metabolism
15.
Lepr Rev ; 82(1): 25-35, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21644469

ABSTRACT

OBJECTIVE: We investigated the in vitro and skin lesions production of cytokines in non-treated borderline tuberculoid (BT) and borderline lepromatous (BL) patients. PATIENTS AND METHODS: Seven untreated, non-reactional BT patients and 12 untreated, non-reactional BL patients were studied. Levels of the cytokines IFN-gamma, IL-10, TGF-beta1 and TNF-alpha were measured in supernantant of peripheral blood mononuclear cells (PBMC) cultures, stimulated with specific M. leprae antigen (sonicated and whole). The cytokines iNOS, IL-10 and TGF-beta1 were detected by immunohistochemistry in skin biopsies. RESULTS: BT patients produced higher levels of IFN-gamma than BL patients; iNOS expression in skin lesions was also higher in BT patients. TGF-beta1 was detected in more cells in BL patients; IL-10 expression was similar in both groups. There was a negative correlation between iNOS and TGF-beta1 expression in skin biopsies, positive correlation between TGF-beta1 in skin lesions and bacillary index, as well as positive correlation between iNOS detected in skin biopsies and PBMC IFN-gamma production. CONCLUSIONS: The BT patients had a mainly a Th1-profile of cytokines in their skin lesions and BL patients had a Th2 profile.


Subject(s)
Cytokines/metabolism , Leprosy, Borderline/metabolism , Leprosy, Lepromatous/metabolism , Leprosy, Tuberculoid/metabolism , Biomarkers/metabolism , Biopsy , Brazil/epidemiology , Female , Humans , Immunohistochemistry , Interferon-gamma/metabolism , Interleukin-10/metabolism , Leprosy, Borderline/epidemiology , Leprosy, Lepromatous/epidemiology , Leprosy, Tuberculoid/epidemiology , Male , Middle Aged , Nitric Oxide Synthase Type II/metabolism , Statistics, Nonparametric , Transforming Growth Factor beta/metabolism , Tumor Necrosis Factor-alpha/metabolism
17.
J Interferon Cytokine Res ; 30(2): 99-105, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20039824

ABSTRACT

Peripheral blood mononuclear cells in lepromatous leprosy (LL) patients produce low levels of interferon-gamma (IFN-gamma) and interleukin-12 (IL-12), and these cells exhibit partial or complete deficiency in the IL-12 receptor. The behavior of the IFN-gamma receptor (IFN-gamma R) has not been described in cells from people with leprosy. We found higher levels of mRNA for IFN-gamma R1 and IFN-gamma R2 in adherent cells stimulated with IFN-gamma and Mycobacterium leprae membrane proteins from LL patients compared with healthy subjects. Flow cytometry showed no significant difference in IFN-gamma R1 expression between LL patients and healthy subjects. Immunoblotting detected only the mature glycosylated form of the 61-67 kDa IFN-gamma R2 protein in healthy subjects. In contrast, cells from LL patients showed three different expression patterns: (1) the immature deglycosylated form of the 34.8 kDa IFN-gamma R2 protein, (2) the mature glycosylated 61-67 kDa form, and (3) both forms. Our data indicate the existence of abnormalities in the intracellular processing and protein expression of the IFN-gamma R in response to specific stimuli such as IFN-gamma and M. leprae membrane proteins in adherent cells of LL patients.


Subject(s)
Leprosy, Lepromatous/metabolism , Leprosy, Lepromatous/pathology , Leukocytes, Mononuclear/metabolism , Leukocytes, Mononuclear/pathology , Receptors, Interferon/genetics , Receptors, Interferon/metabolism , Adult , Cell Adhesion , Female , HeLa Cells , Humans , Male , Middle Aged , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Interferon/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Interferon gamma Receptor
18.
FEMS Microbiol Lett ; 289(1): 72-9, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19054096

ABSTRACT

Mycobacterium leprae survives and replicates within a lipid droplet stored in the enlarged phagosome of histiocytes, a typical feature of lepromatous leprosy that is thought to be an important nutrient source for the bacillus. However, the underlying mechanisms by which lipids accumulate within phagosomes remain unclear. Recently, it was revealed that the lipid droplet-associated proteins, including ADRP and perilipin, play essential roles in lipid accumulation in adipocytes or macrophages. Therefore, we attempted to examine the role of these proteins in leprosy pathogenesis. ADRP and perilipin localized to the phagosomal membrane, which contains M. leprae in skin biopsy specimens of lepromatous leprosy. ADRP expression was transiently increased after phagocytosis in THP-1 cells. However, high levels of ADRP expression persisted only when live M. leprae, but not dead bacilli or latex beads, was added. Furthermore, although peptidoglycan, a Toll-like receptor 2 ligand, suppressed the expression levels of ADRP and perilipin, M. leprae infection inhibited this suppression. These results suggest that live M. leprae has the ability to actively induce and support ADRP/perilipin expression to facilitate the accumulation of lipids within the phagosome and to further maintain a suitable environment for the intracellular survival within the macrophage.


Subject(s)
Gene Expression Regulation , Leprosy, Lepromatous/metabolism , Macrophages/microbiology , Membrane Proteins/metabolism , Mycobacterium leprae/pathogenicity , Phosphoproteins/metabolism , Animals , Carrier Proteins , Cell Line , Humans , Leprosy, Lepromatous/pathology , Macrophages/metabolism , Membrane Proteins/genetics , Mice , Mice, Nude , Perilipin-1 , Perilipin-2 , Phosphoproteins/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Skin/metabolism , Skin/microbiology , Skin/pathology
19.
J Proteome Res ; 6(9): 3669-79, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17658739

ABSTRACT

Validated proteome profile allows better understanding of disease progression, subtype classification, susceptibility patterns, and disease prognosis. Leprosy is a spectral disease, with clinically, histologically, immunologically, and bacteriologically distinguishable subtypes. In addition, a significant fraction of patients undergo immune mediated reactions even after multidrug therapy (MDT). Erythema nodosum leprosum (ENL) is an immune complex mediated reactional condition in leprosy, characterized by a systemic inflammatory condition afflicting borderline lepromatous (BL) and lepromatous leprosy patients (LL). In this study, we have analyzed serum proteome of leprosy patients undergoing ENL reactions and compared it with that of healthy noncontact controls. Depletion of albumin and immunoglobulin G (IgG) was optimized using Aurum serum protein mini kit (Bio-Rad), and then two-dimensional gel electrophoresis (2-DE) of these serum samples was performed. Differentially expressed proteins were identified by MALDI-TOF and MALDI-TOF MS/MS mass spectrometry. Significant increase in one of the isoforms of alpha2 chain of haptoglobin was observed in ENL condition. In addition, haptoglobin phenotype was determined for healthy controls and leprosy patients. Hp 0-0 phenotype was detected in 21.4% of the ENL patients undergoing treatment, which on follow up examination showed typable phenotype, thus showing a condition of acquired anhaptoglobinemia. Since ENL still remains a threat to leprosy disease management, the above findings may provide new insights in understanding the development and progression of this inflammatory condition.


Subject(s)
Blood Proteins/chemistry , Erythema Nodosum/metabolism , Haptoglobins/chemistry , Leprosy, Lepromatous/metabolism , Proteomics/methods , Adult , Amino Acid Sequence , Female , Humans , Immunoglobulin G/chemistry , Male , Middle Aged , Molecular Sequence Data , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
20.
Clin Infect Dis ; 40(2): e5-12, 2005 Jan 15.
Article in English | MEDLINE | ID: mdl-15655736

ABSTRACT

BACKGROUND: Tegumentary leishmaniasis and leprosy display similar spectra of disease phenotypes, which are dependent on cell-mediated immunity to specific antigens. Diffuse cutaneous leishmaniasis and lepromatous leprosy represent the anergic end of the spectrum, whereas mucocutaneous leishmaniasis and tuberculoid leprosy are associated with marked antigen-specific cellular immune response. METHODS: We characterized and compared the cell-mediated response to Leishmania and Mycobacterium leprae antigens in a patient with an intriguing association of mucocutaneous leishmaniasis with lepromatous leprosy, which are at opposite ends of the immunopathological spectra of these diseases. This was done by performance of skin tests and by assessment of the cell proliferation and cytokine production of peripheral blood mononuclear cells (PBMCs). RESULTS: Strong skin-test reactions and PBMC proliferation were observed in response to Leishmania antigens but not to M. leprae antigens. The stimulation of PBMCs with Leishmania and M. leprae antigens induced comparable levels of tumor necrosis factor- alpha , interleukin-5, and interleukin-10. However, the interferon- gamma response to Leishmania antigens was remarkably high, and that to M. leprae antigens was almost nil. CONCLUSIONS: We found that concomitant leprosy and tegumentary leishmaniasis can produce opposite polar forms associated, respectively, with absent or exaggerated cell-mediated immune responses to each pathogen. This suggests that independent mechanisms influence the clinical outcome of each infection. Moreover, interferon- gamma appears to play a major role in the clinical expression of these intracellular infections.


Subject(s)
Antigens, Bacterial/immunology , Antigens, Protozoan/immunology , Interferon-gamma/metabolism , Leishmaniasis, Mucocutaneous/immunology , Leprosy, Lepromatous/immunology , Animals , Antiprotozoal Agents/therapeutic use , Cell Proliferation , Humans , Leishmania/immunology , Leishmaniasis, Mucocutaneous/drug therapy , Leishmaniasis, Mucocutaneous/metabolism , Leprostatic Agents/therapeutic use , Leprosy, Lepromatous/drug therapy , Leprosy, Lepromatous/metabolism , Male , Middle Aged , Mycobacterium leprae/immunology , Neutrophils/immunology , Neutrophils/metabolism , Skin Tests
SELECTION OF CITATIONS
SEARCH DETAIL